glioma stem cells promote radioresistance preferential activation dna damage response
ionizing radiation represents effective therapy glioblastoma world health organization grade iv glioma one lethal human malignancies radiotherapy remains palliative radioresistance mechanisms underlying tumour radioresistance remained elusive show cancer stem cells contribute glioma radioresistance preferential activation dna damage checkpoint response increase dna repair capacity fraction tumour cells expressing cd133 prominin- marker neural stem cells brain cancer stem cells- enriched radiation gliomas cell culture brains immunocompromised mice cd133-expressing glioma cells survive ionizing radiation increased proportions relative tumour cells lack cd133 cd133-expressing tumour cells isolated human glioma xenografts primary patient glioblastoma specimens preferentially activate dna damage checkpoint response radiation repair radiation-induced dna damage effectively cd133-negative tumour cells addition radioresistance cd133-positive glioma stem cells can reversed specific inhibitor chk1 chk2 checkpoint kinases results suggest cd133-positive tumour cells represent cellular population confers glioma radioresistance source tumour recurrence radiation targeting dna damage checkpoint response cancer stem cells may overcome radioresistance provide therapeutic model malignant brain cancers
